Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Integration of Methamphetamine Harm Reduction into Opioid Harm Reduction Services in Iran: Preliminary Results of a Pilot Study

Seyed Ramin Radfar 1 , 2 , Setareh Mohsenifar 3 and Alireza Noroozi 4 , 5 , *
Authors Information
1 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
2 UCLA Integrated Substance Abuse Programs, University of California, Los Angeles, USA
3 HIV/AIDS adviser, United Nation Office on Drugs and Crime (UNODC), Tehran, IR Iran
4 School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences (TUMS), IR Iran
5 Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences (TUMS), Tehran, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e7730
  • Published Online: March 7, 2017
  • Article Type: Original Article
  • Received: July 1, 2016
  • Revised: September 4, 2016
  • Accepted: February 17, 2017
  • DOI: 10.5812/ijpbs.7730

To Cite: Radfar S R, Mohsenifar S, Noroozi A. Integration of Methamphetamine Harm Reduction into Opioid Harm Reduction Services in Iran: Preliminary Results of a Pilot Study, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e7730. doi: 10.5812/ijpbs.7730.

Abstract
Copyright © 2017, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addict Health. 2014; 6(3-4): 146-54[PubMed]
  • 2. Fairbairn N, Kerr T, Buxton JA, Li K, Montaner JS, Wood E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend. 2007; 88(2-3): 313-6[DOI][PubMed]
  • 3. Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse. 1999; 25(3): 475-93[PubMed]
  • 4. Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, et al. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2012; 120(1-3): 119-26[DOI][PubMed]
  • 5. Marshall BD, Wood E, Shoveller JA, Patterson TL, Montaner JS, Kerr T. Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis. BMC Public Health. 2011; 11: 20[DOI][PubMed]
  • 6. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, et al. Meth/amphetamine use and associated HIV: Implications for global policy and public health. Int J Drug Policy. 2010; 21(5): 347-58[DOI][PubMed]
  • 7. Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, et al. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012; 24(12): 1504-13[DOI][PubMed]
  • 8. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003; 188(12): 1820-6[DOI][PubMed]
  • 9. Radfar SR, Sedaghat A, Banihashemi AT, Gouya M, Rawson RA. Behaviors Influencing Human Immunodeficiency Virus Transmission in the Context of Positive Prevention among People Living with HIV/Acquired Immunodeficiency Syndrome in Iran: A Qualitative Study. Int J Prev Med. 2014; 5(8): 976-83[PubMed]
  • 10. Radfar SR, Nematollahi P, Arasteh M. Factors Influencing Access and Use of Care and Treatment Services among Iranian People Living with HIV and AIDS: A Qualitative Study. Iran J Public Health. 2016; 45(1): 109-11[PubMed]
  • 11. Hunter C, Strike C, Barnaby L, Busch A, Marshall C, Shepherd S, et al. Reducing widespread pipe sharing and risky sex among crystal methamphetamine smokers in Toronto: do safer smoking kits have a potential role to play? Harm Reduct J. 2012; 9: 9[DOI][PubMed]
  • 12. Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008; 19(3): 255-64[DOI][PubMed]
  • 13. Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol Rev. 2013; 32(2): 223-4[DOI][PubMed]
  • 14. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013; 24(6)-6[DOI][PubMed]
  • 15. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015; 16: 17-25[DOI][PubMed]
  • 16. Noroozi A, Radfar A, Alam-Mehrjerdi Z, Motevalian SA, Haghdoost AA, Nematollahi P. Bio-behavioural Surveillance Study among Injecting Drug Users (IDUs) and their Sexual Partnersin three cities in Iran. Circulated report. 2011;
  • 17. Radfar SR, Noroozi A, Tayeri K, Motavalian A, Nematollahi P, Mohsenifar S. Study on Prevalence of Alcohol Abuse among Injecting Drug Users in Tehran and 5 Major Cities of Iran. Asia Pac J Med Toxicol. 2014; 3: 20
  • 18. Radfar SR, Cousins SJ, Shariatirad S, Noroozi A, Rawson RA. Methamphetamine use among patients undergoing methadone maintenance treatment in iran; a threat for harm reduction and treatment strategies: A qualitative study. Int J High Risk Behav Addict. 2016; 5(4)[DOI]
  • 19. Baneshi MR, Haghdoost AA, Tarjoman T, Jafari F, Haji Maghsoodi S, Rastegari A. Estimating the size of drug and alcohol users in the country, 2012 [in Persian]. Circulated report. 2012;
  • 20. Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010; (1)[DOI][PubMed]
  • 21. Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges LV, Ramirez G, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002; 30 Suppl 1-93[PubMed]
  • 22. Wechsberg WM, Lam WK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health. 2004; 94(7): 1165-73[PubMed]
  • 23. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004; 99(6): 708-17[DOI][PubMed]
  • 24. Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry. 2006; 163(11): 1993-9[DOI][PubMed]
  • 25. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003; 60(10): 1043-52[DOI][PubMed]
  • 26. Patterson TL, Semple SJ, Fraga M, Bucardo J, de la Torre A, Salazar J, et al. Comparison of sexual and drug use behaviors between female sex workers in Tijuana and Ciudad Juarez, Mexico. Subst Use Misuse. 2006; 41(10-12): 1535-49[DOI][PubMed]
  • 27. Shannon K, Rusch M, Shoveller J, Alexson D, Gibson K, Tyndall MW, et al. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. Int J Drug Policy. 2008; 19(2): 140-7[DOI][PubMed]
  • 28. Lambdin BH, Bruce RD, Chang O, Nyandindi C, Sabuni N, Zamudio-Haas S, et al. Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS One. 2013; 8(6)[DOI][PubMed]
  • 29. MacKenzie JE, Hobfoll SE, Ennis N, Kay J, Jackson A, Lavin J. Reducing AIDS risk among inner-city women: a review of the Collectivist Empowerment AIDS Prevention (CE-AP) Program. J Eur Acad Dermatol Venereol. 1999; 13(3): 166-74[PubMed]
  • 30. Wingood GM, DiClemente RJ. The effects of an abusive primary partner on the condom use and sexual negotiation practices of African-American women. Am J Public Health. 1997; 87(6): 1016-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments